fda approved glp-1 agonists Exploration of the potential association between receptor and suicidal or self-injurious behaviors: a pharmacovigilance study based on the Adverse Event Reporting System database | BMC Medicine Benefits and Risks of GLP-1
Description
2024 May 22;16(20):25869-25878.

Most of the patients had type 2 diabetes

Ma Y, Lee E, Yoshikawa H, Noda T, Miyamoto J, Kimura I, et al

I noticed that I consistently lost weight when I only ate below my blood glucose trigger of 4.8 mmol/L

Meanwhile Mounjaro (tirzepatide), is a dual GLP-1/GIP receptor agonist

GLP-1R is expressed in bone marrow stem cells (BMSCs) [63], osteoblasts, osteocytes [64] and osteoclasts [46], which suggests that it could play a role in both bone tissue destruction and renewal
